Researchers seek participants for lockdown fall-risk study

June 22, 2020
Researchers are seeking participants for a study being done by the Motor Control Research Laboratory within the Department of Kinesiology and Community Health at the University of Illinois at Urbana-Champaign. The purpose of the study is to explore the prevalence and circumstances of falls and fall-related injuries, in relation to physical function and activity levels, in community-dwelling older adults, and those with neurological conditions, such as multiple sclerosis, during the Covid-19-lockdown. 

To participate in the study, visit illinoisahs.co1.qualtrics.com/jfe/form/SV_0dozZJxIH4FdUzz.

Participating in this research study will include completion of an online survey. You will first answer demographic questions (i.e., age, gender, educational level). You will then answer different questions related to your physical activity levels, physical function level, and complete a falls survey asking about previous history of falls. The online survey will take about 15 minutes to complete. Participation in this research is voluntary. If you decide to participate, you are free to withdraw at any time.

Faculty, students, and staff who may see your information will maintain confidentiality to the extent of federal and state laws and university policies. Personal identifiers will not be published or presented. Your de-identified information could be used for future research without additional informed consent.

If you have any questions about the research study, please contact Dr. Jacob Sosnoff, Department of Kinesiology and Community Health, University of Illinois at 217-333-9472, or by e-mail jsosnoff@illinois.edu. If you have questions or concerns about your rights as a participant please contact the University of Illinois at Urbana-Champaign Office for the Protection of Research Subjects at 217-333-2670 or email at irb@illinois.edu.

MS Focus Lending Library


Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more

Study uncovers potential risks of common MS treatment


Study finds an increased risk of events such as stroke, migraine, and depression, and abnormalities in the blood with taking beta interferon for MS.
Learn more